Who
Bobak R. Azamian
President/CEO and Board Chair
Company insider
Files Form 4 as: President/CEO and Board Chair, Tarsus Pharmaceuticals.
In numbers
- Trades disclosed
- 133
- Buys
- 0
- Sells
- 69
- Bought
- $0
- Sold
- $19.7M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Oct 2020
- Last trade
- 4 Sep 2026
- Last filed
- 9 Sep 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $641K7,100 at $90.27 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $265K2,900 at $91.27 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $641K7,100 at $90.27 | filing |
| 4 Sep 2026filed 9 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $265K2,900 at $91.27 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $801K10,000 at $80.06 | filing |
| 2 Sep 2026filed 3 Sep 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $801K10,000 at $80.06 | filing |
| 17 Jun 2026filed 22 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $281K4,582 at $61.24 | filing |
| 17 Jun 2026filed 22 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $335K5,418 at $61.81 | filing |
| 17 Jun 2026filed 22 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $281K4,582 at $61.24 | filing |
| 17 Jun 2026filed 22 Jun 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $335K5,418 at $61.81 | filing |
| 19 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $802K11,964 at $67.00 | filing |
| 19 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $802K11,964 at $67.00 | filing |
| 18 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $802K11,667 at $68.71 | filing |
| 18 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $802K11,667 at $68.71 | filing |
| 17 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $762K10,972 at $69.42 | filing |
| 17 Mar 2026filed 19 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Sold | $762K10,972 at $69.42 | filing |
| 15 Mar 2026filed 17 Mar 2026 | TARS Tarsus PharmaceuticalsBiotechnology | SEC FORM 4 Code M | —66,274 | filing |
| 15 Mar 2026filed 17 Mar 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,300 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —16,975 at $0.00 | filing |
| 15 Mar 2026filed 17 Mar 2026 | TARS Tarsus Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code M | —11,300 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.